Loading clinical trials...
Loading clinical trials...
Exhaled Breath Particles as a Clinical Indicator for Acute and Chronic Rejection After Lung Transplantation
Conditions
Locations
1
Sweden
Skåne University Hospital
Lund, Skåne County, Sweden
Start Date
September 18, 2018
Primary Completion Date
September 1, 2024
Completion Date
September 1, 2026
Last Updated
May 16, 2022
NCT07046910
NCT02812290
NCT00552357
NCT06399302
NCT03697395
NCT03656926
Lead Sponsor
Lund University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions